Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
暂无分享,去创建一个
G. Scambia | A. Ayhan | D. Cibula | H. Akıllı | I. Zapardiel | N. Bizzarri | A. Obermair | N. Abu-Rustum | V. Weinberger | J. Jarkovský | R. Dos Reis | C. Mom | L. V. van Lonkhuijzen | K. Benešová | H. Falconer | M. Meydanlı | K. Aslan | M. Borčinová | R. Pareja | D. Odetto | J. Klat | G. Fons | G. Di Martino | R. Laky | David Isla Ortiz | L. Dostalek | R. A. Salcedo Hernández | R. Poncová | A. Lopez | Jiri Presl
[1] D. Cibula. Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer , 2022, International Journal of Gynecological Cancer.
[2] G. Scambia,et al. CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16) , 2022, International Journal of Gynecological Cancer.
[3] R. Pareja,et al. Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update? , 2022, International Journal of Gynecological Cancer.
[4] F. Landoni,et al. The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. , 2021, European journal of cancer.
[5] M. Morgan,et al. Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors , 2021, International Journal of Gynecological Cancer.
[6] Zheng Feng,et al. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer , 2020, International Journal of Gynecological Cancer.
[7] H. Yagi,et al. Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy? , 2020, Oncology.
[8] A. Ayhan,et al. Comparison of no adjuvant treatment and radiotherapy in early‐stage cervical carcinoma with intermediate risk factors , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[9] J. Cueva,et al. SEOM clinical guidelines for cervical cancer (2019) , 2020, Clinical and Translational Oncology.
[10] H. Westerveld,et al. Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy , 2019, International Journal of Gynecological Cancer.
[11] J. Berek,et al. Revised FIGO staging for carcinoma of the cervix uteri , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[12] L. Dušek,et al. Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature. , 2018, Gynecologic oncology.
[13] E. Åvall-Lundqvist,et al. ESGO Survey on Current Practice in the Management of Cervical Cancer , 2018, International Journal of Gynecologic Cancer.
[14] R. Pötter,et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] D. Cibula,et al. 2017 Update on the Querleu–Morrow Classification of Radical Hysterectomy , 2017, Annals of Surgical Oncology.
[16] H. Dickinson,et al. Radiotherapy and chemoradiation after surgery for early cervical cancer. , 2012, The Cochrane database of systematic reviews.
[17] R. Zaino,et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. , 2006, International journal of radiation oncology, biology, physics.
[18] A. Peters,et al. Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study , 2005, International Journal of Gynecologic Cancer.
[19] B N Bundy,et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. , 1999, Gynecologic oncology.
[20] K. Bilek,et al. Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study. , 1982, Archiv fur Geschwulstforschung.